{"transactions":[{"id":704612,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin. Officer"}}],"security":"Series A Common Stock","published_at":"2026-07-22T20:05:16.000Z","date":"2026-07-20","kind":"sale","planned":false,"acquired":false,"shares":10545,"price":7.7603,"value":81832.3635,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.76 to $7.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":224414,"source":{"system":"sec-edgar","filing":"0001193125-26-312394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526312394/ownership.xml","form_type":"4"}},{"id":756784,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-02T01:14:55.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following May 28, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":7.27,"expiration_date":"2036-05-27","underlying":"Series A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-26-069122","document":"tm2616578-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465926069122/tm2616578-2_4seq1.xml","form_type":"4"}},{"id":890323,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T21:43:57.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":88000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":88000,"derivative":{"exercise_price":5.38,"expiration_date":"2036-02-18","underlying":"Series A Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0001104659-26-018196","document":"tm266959-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465926018196/tm266959-4_4seq1.xml","form_type":"4"}},{"id":890322,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin. Officer"}}],"security":"Series A Common Stock","published_at":"2026-02-20T21:43:57.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":234959,"source":{"system":"sec-edgar","filing":"0001104659-26-018196","document":"tm266959-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465926018196/tm266959-4_4seq1.xml","form_type":"4"}},{"id":907243,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin. Officer"}}],"security":"Series A Common Stock","published_at":"2026-02-12T21:05:13.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":2622,"price":5.3602,"value":14054.4444,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."}],"balance_after":190959,"source":{"system":"sec-edgar","filing":"0001104659-26-014266","document":"tm266207-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465926014266/tm266207-1_4seq1.xml","form_type":"4"}},{"id":1005635,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-06T21:43:41.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":13367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted in connection with the Reporting Person's promotion within the Company. The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":13367,"derivative":{"exercise_price":7.61,"expiration_date":"2035-11-03","underlying":"Series A Common Stock","underlying_shares":13367},"source":{"system":"sec-edgar","filing":"0001104659-25-107806","document":"tm2530509-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465925107806/tm2530509-1_4seq1.xml","form_type":"4"}},{"id":1005634,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin. Officer"}}],"security":"Series A Common Stock","published_at":"2025-11-06T21:43:41.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":9855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted in connection with the Reporting Person's promotion within the Company. Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":193581,"source":{"system":"sec-edgar","filing":"0001104659-25-107806","document":"tm2530509-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465925107806/tm2530509-1_4seq1.xml","form_type":"4"}},{"id":1082710,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Series A Common Stock","published_at":"2025-07-23T20:14:11.000Z","date":"2025-07-21","kind":"sale","planned":false,"acquired":false,"shares":10780,"price":9.1346,"value":98470.988,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."}],"balance_after":183726,"source":{"system":"sec-edgar","filing":"0001104659-25-070013","document":"tm2521574-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465925070013/tm2521574-1_4seq1.xml","form_type":"4"}},{"id":1278478,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:42:54.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":138000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following February 6, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":138000,"derivative":{"exercise_price":4.71,"expiration_date":"2035-02-05","underlying":"Series A Common Stock","underlying_shares":138000},"source":{"system":"sec-edgar","filing":"0001104659-25-010586","document":"tm255919-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465925010586/tm255919-2_4seq1.xml","form_type":"4"}},{"id":1278477,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Series A Common Stock","published_at":"2025-02-07T21:42:54.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following February 6, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":194506,"source":{"system":"sec-edgar","filing":"0001104659-25-010586","document":"tm255919-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465925010586/tm255919-2_4seq1.xml","form_type":"4"}},{"id":1449839,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Series A Common Stock","published_at":"2024-07-23T20:05:50.000Z","date":"2024-07-19","kind":"sale","planned":false,"acquired":false,"shares":10914,"price":3.0997,"value":33830.1258,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."}],"balance_after":160506,"source":{"system":"sec-edgar","filing":"0001104659-24-081891","document":"tm2420000d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924081891/tm2420000d2_4seq1.xml","form_type":"4"}},{"id":1732347,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Series A Common Stock","published_at":"2023-11-21T21:25:50.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":171420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. 25% of the RSUs shall vest on July 18, 2024, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":171420,"source":{"system":"sec-edgar","filing":"0001104659-23-120377","document":"tm2331048-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923120377/tm2331048-4_4seq1.xml","form_type":"4"}},{"id":1825581,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:19:11.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":242142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"timeliness","element":"transactionTimeliness","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option shall vest and become exercisable on April 10, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":242142,"derivative":{"exercise_price":13.51,"expiration_date":"2033-04-19","underlying":"Series A Common Stock","underlying_shares":242142},"source":{"system":"sec-edgar","filing":"0001104659-23-082734","document":"tm2321276-21_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082734/tm2321276-21_4seq1.xml","form_type":"4"}},{"id":1825580,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":29127,"kind":"person","name":"Rozek Elizabeth","position":1,"cik":"0001975022","reported_name":"Rozek Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:19:11.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":242142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"timeliness","element":"transactionTimeliness","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option shall vest and become exercisable on April 10, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":13.51,"expiration_date":"2033-04-19","underlying":"Common Stock","underlying_shares":242142},"source":{"system":"sec-edgar","filing":"0001104659-23-082734","document":"tm2321276-21_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082734/tm2321276-21_4seq1.xml","form_type":"4"}}]}